University of Rochester Medical Center James P. Wilmot Cancer Institute (WCI) was established in 1974 and services over 4,000 patients each year from across the Western New York region and beyond. As the largest cancer center in the region, the WCI employs over 100 physicians and more than 200 registered nurses and nurse practitioners, providing patients and families with comprehensive cancer services. The WCI is an internationally recognized research institution participating in basic science, translational, and clinical trials research with numerous active clinical trials providing access to novel treatments for patients with newly diagnosed and relapsed cancers. The WCI also offers a broad range of support services for patients and families, including a robust survivorship program to assist in a transition to life after their cancer journey. Dr. Jonathan Friedberg, the Principal Investigator for the LEO consortium at the WCI, is the Director of the James P. Wilmot Cancer Center, and Dr. Carla Casulo is co-investigator of the LEO consortium at the WCI. The lymphoma program at the University of Rochester sees approximately 350 new lymphoma patients per year at various stages of disease. As members of the lymphoma program Drs. Friedberg and Casulo strive to provide patients with compassionate care, access to novel treatments, and opportunities for research. They are internationally recognized experts in lymphoma clinical trials and outcomes research.